Generics - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 207 results

PHARMAC tender for generic medicines contributes NZ$38 million savings

PHARMAC tender for generic medicines contributes NZ$38 million savings

18-08-2014

New Zealanders’ use of generic medicines is likely to grow further following the just-completed 2013/14…

Atypical antipsychoticsFinancialGenericsHealthcareNew Zealand

Despite difficult environment, Stada Arz posts solid results

Despite difficult environment, Stada Arz posts solid results

11-08-2014

German generic and branded drugmaker Stada Arzneimittel says that, in the first half of 2014, the group’s…

Business FinanceFinancialGenericsGermanyGermanySTADA Arzneimittel

Mylan’s 2nd-qtr earnings plunge on higher costs and product approval delays

Mylan’s 2nd-qtr earnings plunge on higher costs and product approval delays

07-08-2014

US generics major Mylan has reported that profits dropped nearly 30% in the second quarter of 2014, despite…

Business FinanceChief executiveFinancialFinancial ratiosFundamental analysisGenericsHeather BreschMylanUSA

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

31-07-2014

Israel’s Teva Pharmaceutical Industries, the world’s biggest generics drugmaker, reported disappointing…

CopaxoneFinancialGenericsIsraelTeva Pharmaceutical Industries

Dr Reddy’s achieves quarterly earnings growth of over 50%

Dr Reddy’s achieves quarterly earnings growth of over 50%

31-07-2014

Indian pharmaceutical company Dr Reddy’s has announced quarterly sales of 35.2 billion rupees.

Business FinanceDr Reddy's LaboratoriesFinancialFundamental analysisGenericsHealth Medical PharmaIndia

Ranbaxy down on same quarter last year following FDA fine

Ranbaxy down on same quarter last year following FDA fine

30-07-2014

Indian generic pharma company Ranbaxy, has reported consolidated sales of 23.7 billion rupees ($394 million),…

BSE SensexFinancialGenericsIndiaOver-the-counter accountingPharmaceutical industryRanbaxyRanbaxy Laboratories

Glenmark reports strong growth everywhere but the USA

Glenmark reports strong growth everywhere but the USA

25-07-2014

India-based generics manufacturer Glenmark has seen its consolidated revenue increase by more than 20%…

FinancialGenericsGlenmark PharmaceuticalsIndia

South Africa’s NAPM calls for elimination of VAT on medicines

22-07-2014

South African trade group the National Association of Pharmaceutical Manufacturers (NAPM) has proposed…

FinancialGenericsNational Association of Pharmaceutical ManufacturersPoliticsPricingSouth Africa

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

Cipla to invest £100 million in its UK subsidiary

Cipla to invest £100 million in its UK subsidiary

07-07-2014

Indian drugmaker Cipla has decided to make a significant investment in its UK subsidiary over the next…

CiplaFinancialGenericsMarkets & MarketingResearchUK

Stada will continue to develop emerging markets as domestic growth drops

Stada will continue to develop emerging markets as domestic growth drops

05-06-2014

German generic and branded drugmaker Stada Arzneimittel’s executive board chairman, Hartmut Retzlaff,…

Business FinanceBusiness FinanceFinancialGenericsGermanyPharmaceuticalSTADA ArzneimittelSTADA Pharmaceuticals

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

05-05-2014

The Australian National Commission of Audit’s complete dismantling and destruction of the Pharmaceutical…

AustraliaFinancialGenericsHealthcarePolitics

Teva 1st-qtr 2014 boosted by new generics

Teva 1st-qtr 2014 boosted by new generics

01-05-2014

Israel generic giant Teva Pharmaceutical Industries reported a 2% rise in revenues to $5.0 billion for…

FinancialGenericsTeva Pharmaceutical Industries

Mylan 1st-qtr 2014 revenues miss analysts’ expectations

Mylan 1st-qtr 2014 revenues miss analysts’ expectations

01-05-2014

US generic drugmaker Mylan reported first-quarter 2014 results before markets opened, posting adjusted…

FinancialGenericsMylan

Actavis swings into profit as 1st-qtr 2014 sales leap 40%

Actavis swings into profit as 1st-qtr 2014 sales leap 40%

30-04-2014

Ireland headquartered generics giant Actavis saw its shares rise 2.6% to $203 in mid-morning trading,…

ActavisFinancialGenerics

Philippine government increasing financial support for health care spending

28-03-2014

The size of the Philippine pharmaceutical market, now worth around $3.2 billion, is expected to expand…

Asia-PacificFinancialGenericsMarkets & MarketingPharmaceutical

Solid financials from Stada but outlook sends stock down

Solid financials from Stada but outlook sends stock down

25-03-2014

German generic and branded drugmaker Stada Arzneimittel posted a solid set of financial results for 2013,…

FinancialGenericsSTADA Arzneimittel

AMRI to acquire Cedarburg Pharmaceuticals in $41 million deal

24-03-2014

Albany Molecular Research, a USA-based contract research and manufacturing organization, has signed a…

Albany Molecular ResearchCedarburg PharmaFinancialGenericsMergers & Acquisitions

Generic drugs slow pharma spending growth in Canada

Generic drugs slow pharma spending growth in Canada

13-03-2014

Last year, C$29.3 billion ($26.47 billion) was spent on prescription drugs in Canada, but the annual…

CanadaFinancialGenericsMarkets & MarketingNorth AmericaPharmaceutical

Hikma delivers group revenue growth of 23% and EPS up 111% for 2013

Hikma delivers group revenue growth of 23% and EPS up 111% for 2013

12-03-2014

Jordon-headquartered Hikma Pharmaceuticals today reported its preliminary results for the year ended…

FinancialGenericsHikma Pharmaceuticals

Teva agrees $27.6 million settlement with US Justice Dept

Teva agrees $27.6 million settlement with US Justice Dept

12-03-2014

US subsidiaries of Israeli generics giant Teva Pharmaceutical Industries have agreed to pay the US government…

ClozapineFinancialGenericsIvaxLegalNeurologicalNorth AmericaTeva Pharmaceutical IndustriesUSA

Valeant Pharma returns to profit, boosted by B&L acquisition

27-02-2014

Canadian drugmaker Valeant Pharmaceuticals International has announces fourth quarter financial results…

Bausch & LombFinancialGenericsValeant Pharmaceuticals

1 to 25 of 207 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top